D

Dexcom

5223 employees

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.

Investor insights

Sectors invested in

Medical Device2
AI1
Biotechnology1
Diabetes1
Home Health Care1
Health Care1
the iLet Bionic Pancreas1
biosensor1
Vital Sign Monitoring1
Remote Patient Monitoring1
Telehealth1
Telemonitoring1
Healthcare1
Medical Technology1
Medical Informatics1
Healthcare Technology1

Funding rounds participated in

$34M sweet spot round size

Most of their 2 investments are in rounds between $4.1M and $63M

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
Health Diagnostics
Health Care
Decision Support
Data
Mobile Software
Sensors
Medical Devices
Continuous Glucose Monitoring
Diabetes

Date founded

1999

Investments made

C

Current Health raised $4.1M on June 17, 2020

Investors: MMC Ventures, Par Equity LLP and Dexcom

B

Beta Bionics raised $63M on January 8, 2019

Investors: Zealand Pharma, RTW Investments, LP, Eventide Asset Management, LifeSci Venture Partners and Dexcom

Funding rounds raised

Total raised

$30M

from 7 investors over 7 rounds

D

Dexcom raised $23M on January 6, 2005

Investors: St. Paul Venture Capital, Canaan and Warburg Pincus LLC

D

Dexcom raised $30M on June 3, 2002

Investors: Fog City Capital, St. Paul Venture Capital, Canaan and Windamere Venture Partners

FAQ